These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8059797

  • 1. Treatment of skin and soft-tissue infections utilizing an outpatient parenteral drug delivery device: a multicenter trial. HIAT Study Group.
    Poretz DM.
    Am J Med; 1994 Aug 15; 97(2A):23-7. PubMed ID: 8059797
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of intravenous cefotaxime for treating pneumonia in outpatients.
    Morales JO, Snead H.
    Am J Med; 1994 Aug 15; 97(2A):28-33. PubMed ID: 8059798
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.
    Tassler H.
    Am J Med; 1993 Mar 22; 94(3A):159S-165S. PubMed ID: 8452174
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections.
    Gentry LO, Rodriguez-Gomez G, Zeluff BJ, Khoshdel A, Price M.
    Am J Med; 1989 Dec 29; 87(6C):57S-60S. PubMed ID: 2690621
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
    Pérez-Ruvalcaba JA, Quintero-Pérez NP, Morales-Reyes JJ, Huitrón-Ramírez JA, Rodríguez-Chagollán JJ, Rodríguez-Noriega E.
    Am J Med; 1987 Apr 27; 82(4A):242-6. PubMed ID: 3555042
    [Abstract] [Full Text] [Related]

  • 15. Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting.
    Ektare V, Khachatryan A, Xue M, Dunne M, Johnson K, Stephens J.
    J Med Econ; 2015 Apr 27; 18(12):1092-101. PubMed ID: 26368787
    [Abstract] [Full Text] [Related]

  • 16. Comparative efficacy of cefotiam versus cephalothin in the therapy of skin and soft tissue infections.
    Lentino JR, Stachowski M, Strikas R, Parrillo P.
    Antimicrob Agents Chemother; 1984 Jun 27; 25(6):778-80. PubMed ID: 6331302
    [Abstract] [Full Text] [Related]

  • 17. Ambulatory antibiotic infusion devices: extending the spectrum of outpatient therapies.
    New PB, Swanson GF, Bulich RG, Taplin GC.
    Am J Med; 1991 Nov 27; 91(5):455-61. PubMed ID: 1951407
    [Abstract] [Full Text] [Related]

  • 18. Home intravenous antibiotic therapy. A safe and effective alternative to inpatient care.
    Grayson ML, Silvers J, Turnidge J.
    Med J Aust; 1995 Mar 06; 162(5):249-53. PubMed ID: 7891605
    [Abstract] [Full Text] [Related]

  • 19. Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone.
    Seaton RA, Bell E, Gourlay Y, Semple L.
    J Antimicrob Chemother; 2005 May 06; 55(5):764-7. PubMed ID: 15772137
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.